Yüklüyor......
Febuxostat: the evidence for its use in the treatment of hyperuricemia and gout
INTRODUCTION: Gout is a common and disabling cause of arthritis in middle-aged and elderly populations, with its main predisposing factor being hyperuricemia (serum urate > 6.8 mg/dL). Options for treatment of chronic gout until 2008 were allopurinol, a xanthine oxidase inhibitor, and the group o...
Kaydedildi:
| Asıl Yazarlar: | , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Dove Medical Press
2010
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2899777/ https://ncbi.nlm.nih.gov/pubmed/20694062 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|